About the Center

The Center for Biotechnology and Global Health Policy serves as a reference point for research, policy development and advocacy concerning science, biotechnology, bioethics and healthcare in the United States and abroad. The CBGHP engages multiple stakeholder communities: scholars, policy makers, civil society, healthcare providers, the judiciary and the general public, highlighting the collaborative role and function of law in responding to state, federal and international healthcare concerns.
Prof. Goodwin headshot
Michele Bratcher Goodwin, Chancellor’s Professor of Law, is the Founder and Director of the Center for Biotechnology and Global Health Policy. Her research engages law’s interaction with the body across multiple spheres, encompassing organ transplantation, reproduction, tissue harvesting, sex and marriage trafficking, and international surrogacy, among other topics. More about Prof. Goodwin > | VIDEO: About the Center for Biotechnology and Global Health Policy >

Mission: To educate the public and serve as a catalyst for the advancement of society through research, educational outreach and advocacy.


The Center for Biotechnology and Global Health Policy prioritizes collaborative, cross-cultural and interdisciplinary exchanges, bringing scholars, policy makers, nongovernmental organization members and others to the University of California, Irvine for roundtables, symposia and points of engagement. More about CBGHP Activities >


The Center engages three major initiatives: Public Health and Legal Policy; Reproductive Justice; and Biotechnology and National Security. More about CBGHP Initiatives >